Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suck Chei Choi

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|July 25, 2025
[Seoul Consensus on Clinical Practice Guidelines for Functional Constipation]Kyung Ho Song, Young Sin Cho, Jeong Eun Shin, et al.
Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.
BMC Gastroenterology|December 19, 2023
Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority studyHyun Lim, Jong Kyu Park, Hyunsoo Chung, et al.
Journal of Neurogastroenterology and Motility|July 7, 2023
2022 Seoul Consensus on Clinical Practice Guidelines for Functional ConstipationYoung Sin Cho, Yoo Jin Lee, Jeong Eun Shin, et al.
Journal of Korean Medical Science|September 30, 2017
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority StudyYoon Jin Choi, Dong Ho Lee, Myung Gyu Choi, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2021
Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux diseaseSeung Han Kim, Kwang Bum Cho, Hoon Jai Chun, et al.
Helicobacter|January 19, 2018
Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016Jeong Hoon Lee, Kee Don Choi, Hwoon-Yong Jung, et al.
Helicobacter|October 17, 2015
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide SurveyWoon Geon Shin, Sang Woo Lee, Gwang Ho Baik, et al.
Gut and Liver|February 14, 2025
Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III StudyHyun Lim, Ju Yup Lee, Yong Hwan Kwon, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter StudyDa Hyun Jung, Young Hoon Youn, Hye-Kyung Jung, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|July 25, 2025
[Seoul Consensus on Clinical Practice Guidelines for Functional Constipation]Kyung Ho Song, Young Sin Cho, Jeong Eun Shin, et al.
Neurogastroenterology and Motility|November 26, 2024
Comparison of Tegoprazan and Lansoprazole in Patients With Erosive Esophagitis up to 4 Weeks: A Multi-Center, Randomized, Double-Blind, Active-Comparator Phase 4 TrialCheol Min Shin, Suck Chei Choi, Jin Woong Cho, et al.
BMC Gastroenterology|December 19, 2023
Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority studyHyun Lim, Jong Kyu Park, Hyunsoo Chung, et al.
Journal of Neurogastroenterology and Motility|July 7, 2023
2022 Seoul Consensus on Clinical Practice Guidelines for Functional ConstipationYoung Sin Cho, Yoo Jin Lee, Jeong Eun Shin, et al.
Journal of Korean Medical Science|September 30, 2017
Evaluation of the Efficacy and Safety of DA-9601 versus Its New Formulation, DA-5204, in Patients with Gastritis: Phase III, Randomized, Double-Blind, Non-Inferiority StudyYoon Jin Choi, Dong Ho Lee, Myung Gyu Choi, et al.
Alimentary Pharmacology & Therapeutics|July 6, 2021
Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux diseaseSeung Han Kim, Kwang Bum Cho, Hoon Jai Chun, et al.
Helicobacter|January 19, 2018
Seroprevalence of Helicobacter pylori in Korea: A multicenter, nationwide study conducted in 2015 and 2016Jeong Hoon Lee, Kee Don Choi, Hwoon-Yong Jung, et al.
Helicobacter|October 17, 2015
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide SurveyWoon Geon Shin, Sang Woo Lee, Gwang Ho Baik, et al.
Gut and Liver|February 14, 2025
Evaluation of the Efficacy and Safety of a Dual Delayed-Release Formulation of 10-mg Esomeprazole in Patients with Gastric Erosions: A Multicenter, Randomized, Double-Blind, Active-Control, Phase III StudyHyun Lim, Ju Yup Lee, Yong Hwan Kwon, et al.
Journal of Neurogastroenterology and Motility|October 10, 2023
On-demand Versus Continuous Maintenance Treatment With a Proton Pump Inhibitor for Mild Gastroesophageal Reflux Disease: A Prospective Randomized Multicenter StudyDa Hyun Jung, Young Hoon Youn, Hye-Kyung Jung, et al.
Pageof 17